Anthony Hunt sold $3.3M of RGEN
director at REPLIGEN CORP. 26,447 shares at an average of $123.71, traded May 15, 2025, filed May 16, 2025.
Score components
- +15RoleDirector
- +25Trade size$3.3M at market
- +5Share of holdings soldSold 19% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-073387, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 15, 2025 | SOpen-market sale Common Stock10b5-1 | -2,043 | $122.66 | $251k | 134,258 | May 16, 2025 |
| May 15, 2025 | SOpen-market sale Common Stock10b5-1 | -17,596 | $123.57 | $2.2M | 116,662 | May 16, 2025 |
| May 15, 2025 | SOpen-market sale Common Stock10b5-1 | -6,533 | $124.34 | $812k | 110,129 | May 16, 2025 |
| May 15, 2025 | SOpen-market sale Common Stock10b5-1 | -268 | $125.20 | $34k | 109,861 | May 16, 2025 |
| May 15, 2025 | SOpen-market sale Common Stock10b5-1 | -7 | $127.00 | $889 | 109,854 | May 16, 2025 |
Related signals
Other insiders at REPLIGEN CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 20Weak | REPLIGEN CORP | Olivier Loeillot Chief Executive Officer | $1.0M 5,535 shares | -12% | |
| 20Weak | REPLIGEN CORP | Olivier Loeillot Chief Executive Officer | $2.5M 12,946 shares | -23% | |
| 20Weak | REPLIGEN CORP | Olivier Loeillot Chief Executive Officer | $977k 5,426 shares | -10% | |
| 23Weak | REPLIGEN CORP | Olivier Loeillot Chief Executive Officer | $504k 3,035 shares | -6% | |
| 30Weak | RGENsell REPLIGEN CORP | Anthony Hunt director | $3.5M 29,111 shares | -22% | |
| 53Moderate | RGENbuy REPLIGEN CORP | Martin D Madaus director | $202k 1,800 shares | - | |
| 10Weak | REPLIGEN CORP | Anthony Hunt director | $4.1M 26,756 shares | -16% | |
| 30Weak | RGENsell REPLIGEN CORP | Anthony Hunt director | $3.4M 24,246 shares | -15% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.